Total Payments
$24,784
2024 Payments
$3,651
Companies
74
Transactions
1,174
Medicare Patients
14,408
Medicare Billing
$3.0M
Payment Breakdown by Category
Food & Beverage$24,684 (99.6%)
Education$99.99 (0.4%)
Gifts$0.01 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,684 | 1,172 | 99.6% |
| Education | $99.99 | 1 | 0.4% |
| Gift | $0.01 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $9,186 | 287 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $2,562 | 145 | $0 (2024) |
| Boston Scientific Corporation | $1,967 | 108 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,394 | 111 | $0 (2024) |
| Vertos Medical, Inc. | $1,071 | 42 | $0 (2024) |
| ABBVIE INC. | $931.02 | 41 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $753.46 | 36 | $0 (2024) |
| Daiichi Sankyo Inc. | $437.91 | 33 | $0 (2019) |
| USWM, LLC | $430.27 | 23 | $0 (2022) |
| IBSA Pharma Inc. | $399.56 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,651 | 154 | Abbott Laboratories ($804.75) |
| 2023 | $4,627 | 212 | Abbott Laboratories ($1,741) |
| 2022 | $5,735 | 243 | Abbott Laboratories ($2,613) |
| 2021 | $3,695 | 175 | Abbott Laboratories ($1,829) |
| 2020 | $1,632 | 77 | Abbott Laboratories ($714.74) |
| 2019 | $2,626 | 111 | Abbott Laboratories ($1,335) |
| 2018 | $1,252 | 96 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($234.46) |
| 2017 | $1,567 | 106 | Daiichi Sankyo Inc. ($201.28) |
All Payment Transactions
1,174 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/18/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.23 | General |
| Category: Opioid Analgesic | ||||||
| 12/06/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: Opioid Analgesic | ||||||
| 12/05/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neuromodulation | ||||||
| 11/27/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $36.89 | General |
| Category: INSTRUMENTS | ||||||
| 11/25/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Analgesic | ||||||
| 11/22/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.21 | General |
| Category: Opioid Analgesic | ||||||
| 11/21/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: Opioid Analgesic | ||||||
| 11/20/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Analgesic | ||||||
| 11/20/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Neuromodulation | ||||||
| 11/13/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: INSTRUMENTS | ||||||
| 11/08/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.63 | General |
| Category: Opioid Analgesic | ||||||
| 11/06/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $63.01 | General |
| Category: Neuromodulation | ||||||
| 11/06/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Neuromodulation | ||||||
| 10/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Central Nervous System | ||||||
| 10/24/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Analgesic | ||||||
| 10/15/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/09/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/02/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $28.75 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 3,838 | 12,314 | $5.5M | $862,039 |
| 2022 | 33 | 3,654 | 11,462 | $5.5M | $797,880 |
| 2021 | 38 | 3,872 | 12,492 | $5.9M | $877,724 |
| 2020 | 30 | 3,044 | 9,623 | $2.5M | $488,042 |
Total Patients
14,408
Total Services
45,891
Medicare Billing
$3.0M
Procedure Codes
170
All Medicare Procedures & Services
170 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 662 | 2,698 | $1.8M | $276,329 | 15.7% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 98 | 119 | $684,250 | $94,851 | 13.9% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 179 | 571 | $328,325 | $62,893 | 19.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 183 | 1,188 | $243,896 | $61,513 | 25.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 271 | 943 | $283,100 | $56,598 | 20.0% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 93 | 186 | $186,000 | $44,318 | 23.8% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 106 | 190 | $149,420 | $29,013 | 19.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 102 | 124 | $174,480 | $27,166 | 15.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 77 | 105 | $175,245 | $24,938 | 14.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 115 | $104,074 | $17,379 | 16.7% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 51 | 79 | $127,650 | $15,945 | 12.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 111 | 111 | $93,684 | $14,748 | 15.7% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 22 | 29 | $73,072 | $11,805 | 16.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 63 | 63 | $70,173 | $11,623 | 16.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 21 | 51 | $50,099 | $11,206 | 22.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 681 | 2,811 | $74,912 | $11,204 | 15.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 42 | 68 | $71,816 | $10,289 | 14.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 34 | 49 | $126,215 | $8,547 | 6.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 48 | 71 | $60,496 | $7,673 | 12.7% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 19 | 27 | $38,478 | $6,065 | 15.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 52 | 149 | $29,673 | $5,893 | 19.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 34 | 94 | $90,920 | $5,045 | 5.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 43 | 49 | $76,071 | $5,033 | 6.6% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 30 | 97 | $32,398 | $5,005 | 15.4% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 38 | 48 | $29,753 | $4,756 | 16.0% |
About Dr. Jeremy Jaffe, M.D
Dr. Jeremy Jaffe, M.D is a Specialist healthcare provider based in Abington, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982606182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeremy Jaffe, M.D has received a total of $24,784 in payments from pharmaceutical and medical device companies, with $3,651 received in 2024. These payments were reported across 1,174 transactions from 74 companies. The most common payment nature is "Food and Beverage" ($24,684).
As a Medicare-enrolled provider, Jaffe has provided services to 14,408 Medicare beneficiaries, totaling 45,891 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 170 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Abington, PA
- Active Since 06/01/2005
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1982606182
Products in Payments
- PROCLAIM (Device) $3,423
- XTAMPZA (Drug) $2,414
- WaveWriter Alpha Prime 16 (Device) $1,473
- Proclaim Family of SCS IPGs (Device) $1,335
- Proclaim IPG (Device) $1,315
- RELISTOR (Drug) $1,160
- mild Device Kit (Device) $1,071
- ETERNA (Device) $862.74
- OCTRODE (Device) $683.52
- UBRELVY (Drug) $618.02
- ZTLido (Drug) $592.75
- Octrode SCS Leads (Device) $546.02
- NURTEC ODT (Drug) $428.74
- Lucemyra (Drug) $414.37
- MOVANTIK (Drug) $390.58
- RELISTOR ORAL (Drug) $377.21
- QULIPTA (Drug) $299.06
- Movantik (Drug) $286.76
- Tymlos (Biological) $278.10
- Morphabond ER (Drug) $272.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Abington
Steven Cohen, M.d, M.D
Specialist — Payments: $43,866
Specialist $43,866
Philip Sasso, M.d, M.D
Specialist — Payments: $32,141
Specialist $32,141
Lisette Volckmar, M.d, M.D
Specialist — Payments: $274.46
Specialist $274.46
Luis Mercader, M.d, M.D
Specialist — Payments: $273.90
Specialist $273.90
Robert Atkins, M.d, M.D
Specialist — Payments: $174.94
Specialist $174.94
Peter Vacca, M.d, M.D
Specialist — Payments: $115.46
Specialist $115.46